These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 18280681)
1. Use of clonidine in children with autism spectrum disorders. Ming X; Gordon E; Kang N; Wagner GC Brain Dev; 2008 Aug; 30(7):454-60. PubMed ID: 18280681 [TBL] [Abstract][Full Text] [Related]
2. Clonidine treatment of hyperactive and impulsive children with autistic disorder. Jaselskis CA; Cook EH; Fletcher KE; Leventhal BL J Clin Psychopharmacol; 1992 Oct; 12(5):322-7. PubMed ID: 1479049 [TBL] [Abstract][Full Text] [Related]
3. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137 [TBL] [Abstract][Full Text] [Related]
4. A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. Fankhauser MP; Karumanchi VC; German ML; Yates A; Karumanchi SD J Clin Psychiatry; 1992 Mar; 53(3):77-82. PubMed ID: 1548248 [TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. Connor DF; Fletcher KE; Swanson JM J Am Acad Child Adolesc Psychiatry; 1999 Dec; 38(12):1551-9. PubMed ID: 10596256 [TBL] [Abstract][Full Text] [Related]
6. Guanfacine in children with autism and/or intellectual disabilities. Handen BL; Sahl R; Hardan AY J Dev Behav Pediatr; 2008 Aug; 29(4):303-8. PubMed ID: 18552703 [TBL] [Abstract][Full Text] [Related]
7. Insomnia, night terror, and depression related to clonidine in attention-deficit/hyperactivity disorder. Ghanizadeh A J Clin Psychopharmacol; 2008 Dec; 28(6):725-6. PubMed ID: 19011458 [No Abstract] [Full Text] [Related]
8. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age. Blumer JL; Findling RL; Shih WJ; Soubrane C; Reed MD Pediatrics; 2009 May; 123(5):e770-6. PubMed ID: 19403468 [TBL] [Abstract][Full Text] [Related]
9. Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD. Nair V; Mahadevan S J Trop Pediatr; 2009 Apr; 55(2):116-21. PubMed ID: 19203986 [TBL] [Abstract][Full Text] [Related]
10. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study. Wasserman S; Iyengar R; Chaplin WF; Watner D; Waldoks SE; Anagnostou E; Soorya L; Hollander E Int Clin Psychopharmacol; 2006 Nov; 21(6):363-7. PubMed ID: 17012983 [TBL] [Abstract][Full Text] [Related]
11. Lofexidine in hyperactive and impulsive children with autistic disorder. Niederhofer H; Staffen W; Mair A J Am Acad Child Adolesc Psychiatry; 2002 Dec; 41(12):1396-7. PubMed ID: 12447025 [No Abstract] [Full Text] [Related]
12. An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. Hunt RD; Arnsten AF; Asbell MD J Am Acad Child Adolesc Psychiatry; 1995 Jan; 34(1):50-4. PubMed ID: 7860456 [TBL] [Abstract][Full Text] [Related]
13. Role of risperidone in children with autism spectrum disorder. Chavez B; Chavez-Brown M; Rey JA Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811 [TBL] [Abstract][Full Text] [Related]
14. Decreased use of clonidine following treatment with atomoxetine in children with ADHD. Johnston JA; Ye W; Van Brunt DL; Pohl G; Sumner CR J Clin Psychopharmacol; 2006 Aug; 26(4):389-95. PubMed ID: 16855457 [TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled trial of clonidine in hyperactive children with mental retardation. Agarwal V; Sitholey P; Kumar S; Prasad M Ment Retard; 2001 Aug; 39(4):259-67. PubMed ID: 11448249 [TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Garstang J; Wallis M Child Care Health Dev; 2006 Sep; 32(5):585-9. PubMed ID: 16919138 [TBL] [Abstract][Full Text] [Related]
17. Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities. Valicenti-McDermott MR; Demb H J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):549-60. PubMed ID: 17069544 [TBL] [Abstract][Full Text] [Related]
18. Melatonin for insomnia in children with autism spectrum disorders. Andersen IM; Kaczmarska J; McGrew SG; Malow BA J Child Neurol; 2008 May; 23(5):482-5. PubMed ID: 18182647 [TBL] [Abstract][Full Text] [Related]
19. Sleep disturbances in children with psychiatric disorders. Ivanenko A; Johnson K Semin Pediatr Neurol; 2008 Jun; 15(2):70-8. PubMed ID: 18555193 [TBL] [Abstract][Full Text] [Related]
20. Anxiolytics, adrenergic agents, and naltrexone. Riddle MA; Bernstein GA; Cook EH; Leonard HL; March JS; Swanson JM J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):546-56. PubMed ID: 10230186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]